Aristotle University Of Thessaloniki (AUTH)
Επίδραση της δοξυκυκλίνης στις κλινικές παραμέτρους και στα επίπεδα της μεταλλοπρωτεινάσης-8 (MMP-8) περιοδοντικών ασθενών, με σακχαρώδη διαβήτη τύπου
Abstract
dc:descriptionType 2 diabetes mellitus, caused by the malfunction of insulin-depended glucose and lipid metabolism. Complications of diabetes include retinopathy, nephropathy, neuropathy and cardiovascular disease. Periodontal diseases are infections affecting the periodontium and resulting in the loss of tooth support. There is an association between type 2 diabetes mellitus and periodontitis. Both of these diseases have a relatively high incidence in the general population and common pathways in their pathogenesis. They are polygenic disorders with some degree of immunoregulatory dysfunction. Current studies support a higher incidence and severity of periodontitis in patients with type 2 diabetes mellitus. And other studies show that the prevalence of diabetes in patients with periodontitis is higher that seen in the non-periodontitis patients.Periodontal therapy using scaling and root planning (SRP) intent to control bacterial infection. Although mechanical periodontal therapy is generally effective, in diabetic patients the reduction of bleeding on probing, probing depth and attachment loss is not satisfactory. Treatment studies provide evidence to support periodontal infection has an effect on glycemic control and treating periodontitis can be influential in contributing to glycemic management.In response to endotoxins derived from periodontal pathogens, MMPs and particularly MMP-8 target the destruction of alveolar bone and supporting connective tissues, as osteoclast-related mediator. Furthermore, therapeutic approach that target MMP-8, such as doxycycline, maybe is effective strategy to periodontal management and treatment of high risk patients such as type 2 diabetic patients. Material and MethodsA total of 54 chronic periodontitis patients were included in the present study (29 with type 2 diabetes with HbA1c<7 and 25 systemically healthy). Scaling and root planning (SRP) was performed in all subjects and doxycycline (100mg/daily for 3 weeks) was administered to 15 diabetic patients at 3 months after SRP. Pocket depth, clinical attachment level, recession, bleeding and plaque indices were recorded at baseline and at 3, 6 and 12 months. At the same time points, subgingival plaque samples from 2 sites of each patient were analyzed by "checkerboard" DNA-DNA hybridization for P. gingivalis, T. forsythia, T. denticola, A. actinomycetemcomitans, C. rectus, F. nucleatum, P. nigrescens, P. intermedia and V. parvula and gingival crevicular fluid (GCF) samples from the same sites, as well as blood samples from cephalic vein, were analyzed with ELISA for MMP-8 levels. ResultsClinical and microbiological parameters were homogenous at baseline (Levene’s test, p>0.05), but MMP-8 levels were statistically significantly higher in diabetic patients. Similar clinical and microbiological improvements were observed after SRP for both groups (Mann-Whitney test, p>0.05), while adjunctive doxycycline resulted mainly in statistically significant reduction of MMP-8 levels. Regarding the serum, there was no statistically significant reduction of MMP-8 levels after SRP (Whitney test, p>0.05) and after the use of adjunctive doxycycline (Whitney test, p>0.05).ConclusionFindings from the present study indicate that in well-controlled type 2 diabetic patients the adjunctive use of doxycycline could be beneficial for reduction of MMP-8 levels and therefore controlling subclinical inflammation.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Efthimiades, Nikolaos
- Ευθυμιάδης, Νικόλαος
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28135